Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint (Q44087708)

29 November 2017

Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint (English)

1 reference

left ventricular hypertrophy

29 November 2017

1 reference

1 reference

1 reference

Vasilios Papademetriou

7

1 reference

29 November 2017

15

Björn Dahlöf

0 references

Richard B Devereux

16

object named as

Richard B Devereux

1 reference

29 November 2017

Peter M Okin

1

1 reference

29 November 2017

Jackson T Wright

2

1 reference

29 November 2017

Markku S Nieminen

3

1 reference

29 November 2017

Sverker Jern

4

1 reference

29 November 2017

Anne L Taylor

5

1 reference

29 November 2017

Robert Phillips

6

1 reference

29 November 2017

Luther T Clark

8

1 reference

29 November 2017

Elizabeth O Ofili

9

1 reference

29 November 2017

Otelio S Randall

10

1 reference

29 November 2017

Lasse Oikarinen

11

1 reference

29 November 2017

Matti Viitasalo

12

1 reference

29 November 2017

Lauri Toivonen

13

1 reference

29 November 2017

Stevo Julius

14

1 reference

29 November 2017

1 August 2002

1 reference

Journal of Clinical Hypertension

29 November 2017

1 reference

29 November 2017

15

1 reference

29 November 2017

8

1 reference

29 November 2017

663-671

1 reference

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

An epidemiological study of left ventricular hypertrophy in the biracial population of Evans County, Georgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Ethnic differences in electrocardiographic left ventricular hypertrophy in young and middle-aged employed American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study). Atherosclerosis Risk in Communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Electrocardiographic findings in a healthy biracial population. Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Overview of risk factors for coronary heart disease in black populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the First National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Improved detection of echocardiographic left ventricular hypertrophy using a new electrocardiographic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Transesophageal Echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

Ethnic differences in ECG amplitudes in North American white, black, and Hispanic men and women. Effect of obesity and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Race- and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Comparison of left ventricular mass and geometry in black and white patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Long-term outcomes and modes of death of patients treated with nonthoracotomy implantable defibrillators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic,, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Impact of diabetes on cardiac structure and function: the strong heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902945-X

7 January 2021

10.1016/S0895-7061(02)02945-X

Identifiers

DOI

1 reference

29 November 2017

1 reference